Sorted By:

Relevance


Medicare Monday: Did You Know Four out of Five Part D Prescriptions Are Generic?

PhRMA  |  Blog Post

Premiums for Part D plans have been stable since 2011, and last week CMS announced that average monthly premiums for 2016 Part D plans  will again remain stable, maintaining affordable access to prescription drug coverage for seniors and individuals living with disabilities.
http://catalyst.phrma.org/medicaremonday-did-you-know-four-out-of-five-part-d-prescriptions-are-generic

New Report Shows More than 240 Immuno-Oncology Treatments in Development for Patients with Cancer

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than half a trillion dollars in the search for new treatments and cures, including an estimated $58.8 billion in 2015 alone.
https://www.phrma.org/press-release/new-report-shows-more-than-240-immuno-oncology-treatments-in-development-for-patients-with-cancer

Biopharmaceutical industry policies aim to increase access to clinical trial data

PhRMA  |  Blog Post

PhRMA members have made significant progress in developing processes for clinical trial data access schemes and translating principles into practice. 
http://catalyst.phrma.org/biopharmaceutical-industry-policies-aim-to-increase-access-to-clinical-trial-data

Exchanges Impose High Out-of-Pocket Costs on Patients with Autoimmune Conditions

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/exchanges-impose-high-out-of-pocket-costs-on-patients-with-autoimmune-conditions

Spending on Medicines: The Big Picture

PhRMA  |  Blog Post

For example, in the fight against Alzheimer’s disease, a new innovative medicine that delays the onset of the disease by five years would reduce the number of Americans with this condition by nearly half and reduce the cost of care for Alzheimer's patients by $447 billion a year by 2050.
http://catalyst.phrma.org/spending-on-medicines-the-big-picture

Guest Post: A Cure for Ellie on Leukodystrophy-LBSL

PhRMA  |  Blog Post

Offer your support, no matter how small.
http://catalyst.phrma.org/guest-post-a-cure-for-ellie-on-leukodystrophy-lbsl

4 Reasons Why Importing Drugs is Bad for Patients

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/4-reasons-why-importing-drugs-is-bad-for-patients

Medicare Monday: Call for repeal of IPAB intensifies

PhRMA  |  Blog Post

Learn more about IPAB and why it’s bad for patients here.
http://catalyst.phrma.org/medicare-monday-call-for-repeal-of-ipab-intensifies

Medicines in Development for Cancer 2015 Report

PhRMA  |  Report

In fact, biopharmaceutical companies are developing 836 medicines and vaccines for cancer, all of which are in clinical trials or awaiting review by the U.S.
https://www.phrma.org/report/medicines-in-development-for-cancer-2015-report

List of 2017 Medicines in Development for Alzheimer's

PhRMA  |  Report

This report outlines the medicines in development for Alzheimer's Disease including the drug name, sponsor, indication and development phase.
https://www.phrma.org/report/list-of-2017-medicines-in-development-for-alzheimer-s

Personalized Medicine Leads to Increased Survival Rates: Chronic Leukemias

Chartpack  |  From Our Network

A new wave of molecularly targeted therapies have turned chronic myelogenous leukemia (CML) from a deadly disease into one in which patients live close to normal life spans.
http://chartpack.phrma.org/personal-medicines-in-development-chartpack/benefiting-patients-and-the-health-care-system/personalized-medicine-leads-to-increased-survival-rates-chronic-leukemias

Research in Ohio

PhRMA  |  Research In Your Backyard

What’s more, Ohioans contemplating participation in clinical trials, in consultation with their doctors, have a wide range of choices—nearly 500 tests of new medicines for the six most debilitating chronic diseases in America are underway in communities large and small all over the state and they need patient volunteers.
https://www.phrma.org/research-in-your-backyard/research-in-ohio

This is not a special effect: New video shows the destruction of a rogue cell

PhRMA  |  Blog Post

They are working tirelessly to develop more weapons to combat and destroy these rogue cells, with the hope of one day giving patients the opportunity for a life free of pain.
http://catalyst.phrma.org/this-is-not-a-special-effect-new-video-shows-the-destruction-of-a-rogue-cell

Medicines in Development for Alzheimer's Disease 2017 Report

PhRMA  |  Report

Alzheimer’s is one of the most complex diseases researchers have ever studied.
https://www.phrma.org

High Cholesterol Patient Profile - Sheryl

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/high-cholesterol-patient-profile-sheryl

Week in Review: Building a Brighter Future for Patients

PhRMA  |  Blog Post

You can read more from Joel White here, and be sure to check back in with the series for more questions answered on how we can make medication adherence a non-issue.
http://catalyst.phrma.org/week-in-review-building-a-brighter-future-for-patients

Medicare Monday: PhRMA's comments on new direction for CMMI

PhRMA  |  Blog Post

Read our full comments here, and learn more at PhRMA.org/CMMI.
http://catalyst.phrma.org/medicare-monday-phrmas-comments-on-new-direction-for-cmmi

Burden on Patients: Prescription Management is Critical for Diabetes Patients

PhRMA  |  Blog Post

For patients with diabetes, adhering to their treatment regimens is critical.
http://catalyst.phrma.org/burden-on-patients-prescription-management-is-critical-for-diabetes-patients

New Report Shows 74 Percent of Medicines in Development have Potential to be First-in-Class Treatments

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than half a trillion dollars in the search for new treatments and cures, including an estimated $58.8 billion in 2015 alone.
https://www.phrma.org/press-release/new-report-shows-74-percent-of-medicines-in-development-have-potential-to-be-first-in-class-treatments

Medicines in Development for Children 2012 Report

PhRMA  |  Report

Biopharmaceutical research companies are working to continue this progress and to meet new health challenges specific to children.
https://www.phrma.org/report/medicines-in-development-for-children-report

PhRMA Principles for Responsible Clinical Trial Data Sharing – Certifications

PhRMA  |  Codes & Guidelines

The following list identifies the companies that have provided such certifications to PhRMA as of 05/08/17.
https://www.phrma.org/codes-and-guidelines/phrma-principles-for-responsible-clinical-trial-data-sharing-certifications

Biopharmaceutical Companies’ Personalized Medicine Research Yields Innovative Treatments for Patients

PhRMA  |  Fact Sheet

As scientific understanding has grown, and tools and technologies have advanced, more personalized medicines are progressing through development and reaching patients.
https://www.phrma.org

Patient Profile: How Medicare Part D Extra Help Works- Diane

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/patient-profile-how-medicare-part-d-extra-help-works-diane

Drug Importation: Myths vs. Facts

PhRMA  |  Graphic

Drug importation proponents have perpetuated many myths about the supposed safety and benefits of importation.
https://www.phrma.org/graphic/drug-importation-myths-vs-facts

Exchanges Impose High Out-of-Pocket Costs on Cancer Patients

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/exchanges-impose-high-out-of-pocket-costs-on-cancer-patients

You have reviewed the first 150 results out of 2565. Each page contains 25 results. You're on page 6.

prev 1 2 3 4 5 6 next